Safety and immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccine in adults in Kenya: a phase 1/2 single-blind, randomised controlled trial.
Saved in:
| Title: | Safety and immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccine in adults in Kenya: a phase 1/2 single-blind, randomised controlled trial. |
|---|---|
| Authors: | Hamaluba M; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Sang S; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Orindi B; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Njau I; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Karanja H; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Kamau N; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Gitonga JN; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Mugo D; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Wright D; Oxford Vaccine Group, University of Oxford, Oxford, England, UK., Nyagwange J; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Kutima B; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Omuoyo D; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Mwatasa M; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Ngetsa C; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Agoti C; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Cheruiyot S; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Nyaguara A; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Munene M; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Mturi N; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Oloo E; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Ochola-Oyier L; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Mumba N; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Mauncho C; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Namayi R; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Davies A; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.; Centre for Tropical Medicine & Global Health, University of Oxford, Oxford, England, UK., Tsofa B; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Nduati EW; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Aliyan N; Ministry of Health, Nairobi, Kenya., Kasera K; Ministry of Health, Nairobi, Kenya., Etyang A; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Boyd A; The Jenner Institute, University of Oxford, Oxford, England, UK., Hill A; The Jenner Institute, University of Oxford, Oxford, England, UK., Gilbert S; Pandemic Sciences Institute, University of Oxford, Oxford, England, UK., Douglas A; The Jenner Institute, University of Oxford, Oxford, England, UK., Pollard A; Oxford Vaccine Group, University of Oxford, Oxford, England, UK., Bejon P; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.; Centre for Tropical Medicine & Global Health, University of Oxford, Oxford, England, UK., Lambe T; Oxford Vaccine Group, University of Oxford, Oxford, England, UK.; Pandemic Sciences Institute, University of Oxford, Oxford, England, UK., Warimwe G; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.; Centre for Tropical Medicine & Global Health, University of Oxford, Oxford, England, UK. |
| Corporate Authors: | COV004 Vaccine Trial Group |
| Source: | Wellcome open research [Wellcome Open Res] 2023 Nov 27; Vol. 8, pp. 182. Date of Electronic Publication: 2023 Nov 27 (Print Publication: 2023). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wellcome Trust Country of Publication: England NLM ID: 101696457 Publication Model: eCollection Cited Medium: Print ISSN: 2398-502X (Print) Linking ISSN: 2398502X NLM ISO Abbreviation: Wellcome Open Res Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38707489 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Safety and immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccine in adults in Kenya: a phase 1/2 single-blind, randomised controlled trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Hamaluba+M%22">Hamaluba M</searchLink>; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.<br /><searchLink fieldCode="AU" term="%22Sang+S%22">Sang S</searchLink>; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.<br /><searchLink fieldCode="AU" term="%22Orindi+B%22">Orindi B</searchLink>; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.<br /><searchLink fieldCode="AU" term="%22Njau+I%22">Njau I</searchLink>; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.<br /><searchLink fieldCode="AU" term="%22Karanja+H%22">Karanja H</searchLink>; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.<br /><searchLink fieldCode="AU" term="%22Kamau+N%22">Kamau N</searchLink>; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.<br /><searchLink fieldCode="AU" term="%22Gitonga+JN%22">Gitonga JN</searchLink>; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.<br /><searchLink fieldCode="AU" term="%22Mugo+D%22">Mugo D</searchLink>; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.<br /><searchLink fieldCode="AU" term="%22Wright+D%22">Wright D</searchLink>; Oxford Vaccine Group, University of Oxford, Oxford, England, UK.<br /><searchLink fieldCode="AU" term="%22Nyagwange+J%22">Nyagwange J</searchLink>; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.<br /><searchLink fieldCode="AU" term="%22Kutima+B%22">Kutima B</searchLink>; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.<br /><searchLink fieldCode="AU" term="%22Omuoyo+D%22">Omuoyo D</searchLink>; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.<br /><searchLink fieldCode="AU" term="%22Mwatasa+M%22">Mwatasa M</searchLink>; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.<br /><searchLink fieldCode="AU" term="%22Ngetsa+C%22">Ngetsa C</searchLink>; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.<br /><searchLink fieldCode="AU" term="%22Agoti+C%22">Agoti C</searchLink>; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.<br /><searchLink fieldCode="AU" term="%22Cheruiyot+S%22">Cheruiyot S</searchLink>; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.<br /><searchLink fieldCode="AU" term="%22Nyaguara+A%22">Nyaguara A</searchLink>; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.<br /><searchLink fieldCode="AU" term="%22Munene+M%22">Munene M</searchLink>; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.<br /><searchLink fieldCode="AU" term="%22Mturi+N%22">Mturi N</searchLink>; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.<br /><searchLink fieldCode="AU" term="%22Oloo+E%22">Oloo E</searchLink>; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.<br /><searchLink fieldCode="AU" term="%22Ochola-Oyier+L%22">Ochola-Oyier L</searchLink>; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.<br /><searchLink fieldCode="AU" term="%22Mumba+N%22">Mumba N</searchLink>; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.<br /><searchLink fieldCode="AU" term="%22Mauncho+C%22">Mauncho C</searchLink>; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.<br /><searchLink fieldCode="AU" term="%22Namayi+R%22">Namayi R</searchLink>; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.<br /><searchLink fieldCode="AU" term="%22Davies+A%22">Davies A</searchLink>; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.; Centre for Tropical Medicine & Global Health, University of Oxford, Oxford, England, UK.<br /><searchLink fieldCode="AU" term="%22Tsofa+B%22">Tsofa B</searchLink>; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.<br /><searchLink fieldCode="AU" term="%22Nduati+EW%22">Nduati EW</searchLink>; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.<br /><searchLink fieldCode="AU" term="%22Aliyan+N%22">Aliyan N</searchLink>; Ministry of Health, Nairobi, Kenya.<br /><searchLink fieldCode="AU" term="%22Kasera+K%22">Kasera K</searchLink>; Ministry of Health, Nairobi, Kenya.<br /><searchLink fieldCode="AU" term="%22Etyang+A%22">Etyang A</searchLink>; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.<br /><searchLink fieldCode="AU" term="%22Boyd+A%22">Boyd A</searchLink>; The Jenner Institute, University of Oxford, Oxford, England, UK.<br /><searchLink fieldCode="AU" term="%22Hill+A%22">Hill A</searchLink>; The Jenner Institute, University of Oxford, Oxford, England, UK.<br /><searchLink fieldCode="AU" term="%22Gilbert+S%22">Gilbert S</searchLink>; Pandemic Sciences Institute, University of Oxford, Oxford, England, UK.<br /><searchLink fieldCode="AU" term="%22Douglas+A%22">Douglas A</searchLink>; The Jenner Institute, University of Oxford, Oxford, England, UK.<br /><searchLink fieldCode="AU" term="%22Pollard+A%22">Pollard A</searchLink>; Oxford Vaccine Group, University of Oxford, Oxford, England, UK.<br /><searchLink fieldCode="AU" term="%22Bejon+P%22">Bejon P</searchLink>; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.; Centre for Tropical Medicine & Global Health, University of Oxford, Oxford, England, UK.<br /><searchLink fieldCode="AU" term="%22Lambe+T%22">Lambe T</searchLink>; Oxford Vaccine Group, University of Oxford, Oxford, England, UK.; Pandemic Sciences Institute, University of Oxford, Oxford, England, UK.<br /><searchLink fieldCode="AU" term="%22Warimwe+G%22">Warimwe G</searchLink>; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.; Centre for Tropical Medicine & Global Health, University of Oxford, Oxford, England, UK. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22COV004+Vaccine+Trial+Group%22">COV004 Vaccine Trial Group</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101696457%22">Wellcome open research</searchLink> [Wellcome Open Res] 2023 Nov 27; Vol. 8, pp. 182. <i>Date of Electronic Publication: </i>2023 Nov 27 (<i>Print Publication: </i>2023). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wellcome+Trust%22">Wellcome Trust </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101696457 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2398-502X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222398502X%22">2398502X </searchLink><i>NLM ISO Abbreviation: </i>Wellcome Open Res <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38707489 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.12688/wellcomeopenres.19150.2 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 182 Titles: – TitleFull: Safety and immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccine in adults in Kenya: a phase 1/2 single-blind, randomised controlled trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Hamaluba M – PersonEntity: Name: NameFull: Sang S – PersonEntity: Name: NameFull: Orindi B – PersonEntity: Name: NameFull: Njau I – PersonEntity: Name: NameFull: Karanja H – PersonEntity: Name: NameFull: Kamau N – PersonEntity: Name: NameFull: Gitonga JN – PersonEntity: Name: NameFull: Mugo D – PersonEntity: Name: NameFull: Wright D – PersonEntity: Name: NameFull: Nyagwange J – PersonEntity: Name: NameFull: Kutima B – PersonEntity: Name: NameFull: Omuoyo D – PersonEntity: Name: NameFull: Mwatasa M – PersonEntity: Name: NameFull: Ngetsa C – PersonEntity: Name: NameFull: Agoti C – PersonEntity: Name: NameFull: Cheruiyot S – PersonEntity: Name: NameFull: Nyaguara A – PersonEntity: Name: NameFull: Munene M – PersonEntity: Name: NameFull: Mturi N – PersonEntity: Name: NameFull: Oloo E – PersonEntity: Name: NameFull: Ochola-Oyier L – PersonEntity: Name: NameFull: Mumba N – PersonEntity: Name: NameFull: Mauncho C – PersonEntity: Name: NameFull: Namayi R – PersonEntity: Name: NameFull: Davies A – PersonEntity: Name: NameFull: Tsofa B – PersonEntity: Name: NameFull: Nduati EW – PersonEntity: Name: NameFull: Aliyan N – PersonEntity: Name: NameFull: Kasera K – PersonEntity: Name: NameFull: Etyang A – PersonEntity: Name: NameFull: Boyd A – PersonEntity: Name: NameFull: Hill A – PersonEntity: Name: NameFull: Gilbert S – PersonEntity: Name: NameFull: Douglas A – PersonEntity: Name: NameFull: Pollard A – PersonEntity: Name: NameFull: Bejon P – PersonEntity: Name: NameFull: Lambe T – PersonEntity: Name: NameFull: Warimwe G IsPartOfRelationships: – BibEntity: Dates: – D: 27 M: 11 Text: 2023 Nov 27 Type: published Y: 2023 Identifiers: – Type: issn-print Value: 2398-502X Numbering: – Type: volume Value: 8 Titles: – TitleFull: Wellcome open research Type: main |
| ResultId | 1 |